News
Pulmonary Embolism Rule-Out Criteria Strategy is noninferior when clinical probability is low
July 30, 2018
Can low probability pulmonary embolism (PE) be safely excluded using the Pulmonary Embolism Rule-Out Criteria?
News
After initial rivaroxaban, aspirin is noninferior to rivaroxaban for thromboprophylaxis following joint arthroplasty
July 27, 2018
Is aspirin as effective as rivaroxaban at reducing rates of symptomatic venous thromboembolism (VTE) after hip or knee arthroplasty?
News
DOACs’ safety affirmed in real-world setting
July 9, 2018
Direct oral anticoagulants were linked with lower bleeding risk, regardless of reason for use. One shone brightest.
News
ICH: Recent NOAC use associated with lower risk of in-hospital mortality, compared with warfarin
July 9, 2018
Among patients presenting with an intracerebral hemorrhage (ICH), what is the association between recent anticoagulant use and in-hospital mortality?
News
New look at ATLAS suggests rivaroxaban may still have role in ACS
July 2, 2018
A reanalysis of the ATLAS ACS 2-TIMI 51 trial separated fatal and nonfatal events.
News
Myeloproliferative neoplasms increase risk for arterial and venous thrombosis
July 2, 2018
What are the risks for arterial and venous thrombosis in patients with myeloproliferative neoplasms (MPNs)?
News
RBC transfusions with surgery may increase VTE risk
June 14, 2018
Stricter blood management practices and VTE prophylaxis may be needed if the study findings are confirmed.
News
DOAC’s edge over warfarin fades with low adherence
June 12, 2018
BOSTON – When atrial fib patients adhere to a direct oral anticoagulant it outperforms warfarin, but when compliance falls the tables get turned.
News
Skip the catheter-directed thrombolytics
May 30, 2018
Does the addition of catheter-directed thrombolysis to standard therapy with anticoagulation reduce the risk of the postthrombotic syndrome in proximal DVT?
News
LAAC in nonvalvular AF provides stroke protection comparable to warfarin
May 24, 2018
Is mechanical left atrial appendage closure (LAAC) as effective as warfarin at preventing stroke in patients with nonvalvular atrial fibrillation?